SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technical analysis for shorts & longs
SPY 680.44+0.6%Dec 19 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: da_spot who wrote (53516)12/20/2020 5:29:06 PM
From: Johnny Canuck  Read Replies (4) of 69155
 
Thanks for posting.

Only had a chance to hear the first part of the interview. Will listen to the whole thing later.

Interestingly I was just talking to someone in Friday about the COVID-19 vaccine and how vaccines have changed because of the ability to sequence DNA. Some of the current vaccines for COVID-19 does not use a inert version of the virus, the historical approach. They rather take parts of the DNA sequences of the virus that targets the delivery mechanism of the virus so your body builds up an immunity to deal with delivery mechanism. Since the delivery mechanism does not change fundamentally mutations of the virus are less effective.

Keep in mind I am hearing this second hand from someone whose brother is a doctor and only involved at the peripheral parts of the vaccine deployment process.

The problem I find with the bio-tech and the pharm industry is it is hard to pick the winners and losers unless you are an insider and know the industry intimately. It is more about having enough darts in a certain area that shows promise as opposed to picking one horse.

Case in point the little blue pills for sexual disfunction was actually designed to be a heart medicine. The side effect was what makes the pills attractive to older men not the intended application.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News